Patent Assignment
Reel/Frame 032946/0110
Change of Name
Recorded: 2014-05-22
Pages: 5
Assignor
SUPERGEN, INC.
Executed: 2011-09-09
Assignee
ASTEX PHARMACEUTICALS, INC.
436 CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0QA, UNITED KINGDOM
Covered Properties
(4)
Compositions and Methods for Reestablishing Gene Transcription Through Inhibition of Dna Methylation and Histone Deacetylase
Kit for Delivering Decitabine in Vivo
Method of Administering Decitabine
Methods for Treating Hematological Disorders Through Inhibition of Dna Methylation and Histone Deacetylase
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 23, 2001
From: DIMARTINO, JORGE
To: SUPERGEN, INC.
Reel/Frame 012023/0036 →
Assignment of Assignor's Interest
Jul 13, 2004
From: JOSHI-HANGAL, RAJASHREE; ZHANG, XICHEN; GONG, STEPHANIE; REDKAR, SANJEEV
To: SUPERGEN, INC.
Reel/Frame 015574/0791 →
Assignment of Assignor's Interest
Jul 13, 2004
From: JOSHI-HANGAL, RAJASHREE; ZHANG, XICHEN; GONG, STEPHANIE; REDKAR, SANJEEV
To: SUPERGEN, INC.
Reel/Frame 015579/0768 →
Assignment of Assignor's Interest
Mar 15, 2005
From: DIMARTINO, JORGE
To: SUPERGEN, INC.
Reel/Frame 016394/0623 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 032946 Frame 0110. Assignor(S) Hereby Confirms the Correct Address for Receiving Party.
Jul 3, 2014
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 033276/0328 →
Change of Assignee Address
Jan 21, 2016
From: ASTEX PHARMACEUTICALS, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 037567/0907 →